Distribution of concurrent Chlamydia trachomatis serovars per sampling site
| Patients (n=11) | Cervix | Vagina | Urethra | Rectum | Urine |
| OPD O&G | |||||
| Female | I group (G/Ga) | ||||
| C group (?) | |||||
| Female | C group (H) | ||||
| C group (K) | |||||
| Female | B group (E) | ||||
| C group (?) | |||||
| Female | B group (D/Da) | ||||
| C group (?) | |||||
| STD clinic | |||||
| Female | I group (F) | ||||
| C group (?) | |||||
| Female | B group (E) | ||||
| C group (J) | |||||
| Female | C group (H) | ||||
| C group (K) | |||||
| Female | B group (E) | ||||
| C group (J) | |||||
| Male | I group (F) | ||||
| I group (G/Ga) | |||||
| Male | B group (E) | ||||
| C group (K) | |||||
| Male | B group (E) | ||||
| I group (F) | |||||
Serovars presented as serogroup with serovar.
OPD O&G, outpatient department of obstetrics and gynaecology; STD, sexually transmitted disease; ?, unknown/untypeable serovar (possible explanations are given in the discussion).